EDITORIAL
Published on 04 Apr 2024
Editorial: Advances in molecular and pharmacological mechanisms of novel targeted therapies for melanoma
doi 10.3389/fonc.2024.1403778
- 366 views
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Advances in Molecular and Pharmacological Mechanisms of Novel Targeted Therapies for Melanoma
Advances in Molecular and Pharmacological Mechanisms of Novel Targeted Therapies for Melanoma
8,239
Total downloads
29k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 29 Jan 2024
Mechanisms underlying the therapeutic effects of cinobufagin in treating melanoma based on network pharmacology, single-cell RNA sequencing data, molecular docking, and molecular dynamics simulation
doi 10.3389/fphar.2023.1315965
- 3,210 views
- 1 citation
ORIGINAL RESEARCH
Published on 21 Sep 2023
Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor
doi 10.3389/fphar.2023.1271268
- 2,816 views
- 3 citations
CASE REPORT
Published on 20 Sep 2023
Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma
doi 10.3389/fonc.2023.1276729
- 1,155 views
- 1 citation
REVIEW
Published on 19 Sep 2023
Ferroptosis as a promising therapeutic strategy for melanoma
doi 10.3389/fphar.2023.1252567
- 2,694 views
- 11 citations
BRIEF RESEARCH REPORT
Published on 18 Sep 2023
Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells
doi 10.3389/fonc.2023.1182853
- 1,162 views
- 1 citation
ORIGINAL RESEARCH
Published on 06 Sep 2023
Bioinformatics-based analysis reveals elevated CYTL1 as a potential therapeutic target for BRAF-mutated melanoma
doi 10.3389/fcell.2023.1171047
- 1,453 views
ORIGINAL RESEARCH
Published on 17 Aug 2023
Causal association between serum 25-Hydroxyvitamin D levels and cutaneous melanoma: a two-sample Mendelian randomization study
doi 10.3389/fonc.2023.1154107
- 2,461 views
- 4 citations
ORIGINAL RESEARCH
Published on 23 Jun 2023
Mapping knowledge landscapes and emerging trends of the biomarkers in melanoma: a bibliometric analysis from 2004 to 2022
doi 10.3389/fonc.2023.1181164
- 3,303 views
- 6 citations
ORIGINAL RESEARCH
Published on 14 Jun 2023
ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma
doi 10.3389/fonc.2023.1181537
- 1,688 views
- 3 citations
CASE REPORT
Published on 03 May 2023
Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report
doi 10.3389/fonc.2023.1167791
- 3,359 views
- 2 citations
CASE REPORT
Published on 20 Apr 2023
Operative management of immune checkpoint colitis following in-transit melanoma: Case report
doi 10.3389/fonc.2023.1120808
- 1,151 views
- 1 citation
Published in
Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Skin Cancer
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 29kTopic views
- 20kArticle views
- 8,239Article downloads